Harte-Hanks
6 hedge funds and large institutions have $460K invested in Harte-Hanks in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 18 closing their positions.
74% less funds holding
Funds holding: 23 → 6 (-17)
93% less capital invested
Capital invested by funds: $6.9M → $460K (-$6.44M)
94% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 18
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EVC
Eidelman Virant Capital
Saint Louis,
Missouri
|
+$163K |
| 2 |
FCH
Freestone Capital Holdings
Seattle,
Washington
|
+$573 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair & Company
Chicago,
Illinois
|
-$2.01M |
| 2 |
FM
Fondren Management
Houston,
Texas
|
-$1.66M |
| 3 |
Renaissance Technologies
New York
|
-$881K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$439K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$393K |
HHS Hedge Fund Activity: Q3 2020 in Review
6 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Harte-Hanks (HHS) for Q3 2020, worth a combined $460K — down 93% from $6.9M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of HHS and 1 opened new positions — a net loss of 17 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Eidelman Virant Capital, adding an estimated $163K. The largest seller was William Blair & Company, exiting entirely with an estimated $2.01M sold.
- 6 institutional investors held Harte-Hanks (HHS) as of Q3 2020, down from 23 in Q2 2020.
- Funds reported $460K of Harte-Hanks stock for Q3 2020, down 93% quarter-over-quarter.
- 1 fund opened new Harte-Hanks positions in Q3 2020 and 18 closed out, a net change of -17 holders.
- The largest Harte-Hanks buyer in Q3 2020 was Eidelman Virant Capital, an estimated $163K added.
- The largest Harte-Hanks seller in Q3 2020 was William Blair & Company, an estimated $2.01M sold.
Based on aggregated 13F filings for Q3 2020.